EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Percutaneous Left Atrial Appendage Closure in Patients With Cardioembolic Breakthrough Stroke: An International Observational Study

Roberto Galea, Gavino Casu, Tommaso Bini, Angelo Laconi, Pier Luigi Merella iD, Konstantina Chalkou, Alberto Preda, Marco Cerciello, Giuseppe D'Angelo iD, Paolo Della Bella, Patrizio Mazzone, Elias Auer und 4 weitere

European Journal of Neurology · 2025

DOI: 10.1111/ene.70365 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Roberto Galea und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Ischemic Stroke, Embolic Stroke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with non‐valvular atrial fibrillation (AF) who experience an ischemic stroke despite oral anticoagulation (OAC) are at particularly high risk of recurrence, with a reported annualized ischemic stroke rate of 5.3%–8.9%. The optimal strategy for secondary prevention in these patients remains unknown.

Methods

We reviewed all percutaneous left atrial appendage closures (LAAC) attempted in AF patients experiencing an ischemic stroke under OAC and who were prospectively collected in four European centers. All index strokes were categorized by an experienced neurologist to exclude patients with non‐cardioembolic etiology or insufficient OAC. The primary endpoint was a recurrent ischemic stroke at 2 years after the procedure. Secondary endpoints included procedure‐related complications and 2‐year death.

Results

Of 2234 patients submitted to LAAC procedure, 95 had a cardioembolic breakthrough stroke. LAAC procedures were performed at a mean of 4 months after the breakthrough stroke. The main antithrombotic therapy at discharge (83%) and at the latest follow‐up (79%) consisted of OAC. At the median follow‐up of 713 days, the primary endpoint occurred in 4 patients (4%). Procedure‐related complications were rare (1%) whereas death occurred in 5% of patients.

Conclusion

LAAC procedures were safe and feasible in patients with cardioembolic breakthrough stroke. Recurrent stroke rates were lower than those reported in previous studies with OAC continuation after breakthrough stroke, suggesting a potential additive protection by LAAC on top of OAC. Results from ongoing randomized trials are required to validate our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationIschemic StrokeEmbolic StrokeStrokeHumansMaleFemaleAgedAged, 80 and overMiddle AgedSecondary PreventionAnticoagulantsRecurrenceProspective StudiesLeft Atrial Appendage Closure

Stichwörter der Autor:innen

atrial fibrillationbreakthrough strokeleft atrial appendage closureoral anticoagulationstroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Cardiology, Hospital Centre of Biel, Biel, Switzerland.
  • Clinical and Interventional Cardiology, University of Sassari, Sassari, Italy.
  • Graduate School for Health Sciences, University of Bern, Bern, Switzerland.
  • Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.

ORCID-Profile: Pier Luigi Merella, Giuseppe D'Angelo

Zitieren

APA

Galea, R., Casu, G., Bini, T., Laconi, A., Merella, P. L., Chalkou, K., Preda, A., Cerciello, M., D'Angelo, G., Bella, P. D., Mazzone, P., Auer, E., Gasys, A., Seiffge, D. J., Fischer, U., & Räber, L. (2025). Percutaneous Left Atrial Appendage Closure in Patients With Cardioembolic Breakthrough Stroke: An International Observational Study. European Journal of Neurology. https://doi.org/10.1111/ene.70365

Vancouver

Galea R, Casu G, Bini T, Laconi A, Merella PL, Chalkou K, et al. Percutaneous Left Atrial Appendage Closure in Patients With Cardioembolic Breakthrough Stroke: An International Observational Study. European Journal of Neurology. 2025. doi:10.1111/ene.70365

BibTeX
@article{Galea2025,
  author = {Galea, Roberto and Casu, Gavino and Bini, Tommaso and Laconi, Angelo and Merella, Pier Luigi and Chalkou, Konstantina and Preda, Alberto and Cerciello, Marco and D'Angelo, Giuseppe and Bella, Paolo Della and Mazzone, Patrizio and Auer, Elias and Gasys, Antanas and Seiffge, David Julian and Fischer, Urs and Räber, Lorenz},
  title = {Percutaneous Left Atrial Appendage Closure in Patients With Cardioembolic Breakthrough Stroke: An International Observational Study},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70365}
}
Kostenlos starten →